These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29900105)

  • 1. Systemic amyloidoses and proteomics: The state of the art.
    Lavatelli F; di Fonzo A; Palladini G; Merlini G
    EuPA Open Proteom; 2016 Jun; 11():4-10. PubMed ID: 29900105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics.
    Rognoni P; Mazzini G; Caminito S; Palladini G; Lavatelli F
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F; Vrana JA
    Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in protein misfolding diseases.
    Stoppini M; Obici L; Lavatelli F; Giorgetti S; Marchese L; Moratti R; Bellotti V; Merlini G
    Clin Chem Lab Med; 2009; 47(6):627-35. PubMed ID: 19527136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pathology of Amyloidosis in Classification: A Review.
    Picken MM
    Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in proteomic study of cardiac amyloidosis: progress and potential.
    Lavatelli F; Merlini G
    Expert Rev Proteomics; 2016 Nov; 13(11):1017-1027. PubMed ID: 27678147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of systemic amyloid diseases.
    Obici L; Perfetti V; Palladini G; Moratti R; Merlini G
    Biochim Biophys Acta; 2005 Nov; 1753(1):11-22. PubMed ID: 16198646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
    Lavatelli F; Merlini G
    Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.
    Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Rossi R; Palladini G; Obici L; Verga L; Mauri P; Merlini G
    Blood; 2012 Feb; 119(8):1844-7. PubMed ID: 21917755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers in early diagnosis and management of systemic amyloidoses.
    Lavatelli F; Albertini R; Di Fonzo A; Palladini G; Merlini G
    Clin Chem Lab Med; 2014 Nov; 52(11):1517-31. PubMed ID: 24870609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic amyloidosis: novel therapies and role of biomarkers.
    Nuvolone M; Merlini G
    Nephrol Dial Transplant; 2017 May; 32(5):770-780. PubMed ID: 27540044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidosis: Insights from Proteomics.
    Dogan A
    Annu Rev Pathol; 2017 Jan; 12():277-304. PubMed ID: 27959636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirming the Diagnosis of Amyloidosis.
    Wisniowski B; Wechalekar A
    Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
    Picken MM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement.
    Schreml S; Szeimies RM; Vogt T; Landthaler M; Schroeder J; Babilas P
    Eur J Dermatol; 2010; 20(2):152-60. PubMed ID: 20071301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification of amyloidosis].
    Misumi Y; Ando Y
    Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The workings of the amyloid diseases.
    Bellotti V; Nuvolone M; Giorgetti S; Obici L; Palladini G; Russo P; Lavatelli F; Perfetti V; Merlini G
    Ann Med; 2007; 39(3):200-7. PubMed ID: 17457717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses.
    Nevone A; Merlini G; Nuvolone M
    Front Pharmacol; 2020; 11():1024. PubMed ID: 32754033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.
    Spodzieja M; Rodziewicz-Motowidło S; Szymanska A
    Curr Med Chem; 2019; 26(1):104-120. PubMed ID: 28971756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.